Pharmaceutical Journal Personalising antidepressants: should we be genetic testing? by michelesolisJuly 7, 2022 Some health systems are already using pharmacogenomic testing to help tailor treatment for depression, but experts say the evidence for this approach is not quite there yet. Read this at Pharmaceutical Journal. Share this:TwitterFacebookLike this:Like Loading... Post navigation Previous Post Next Post
Some health systems are already using pharmacogenomic testing to help tailor treatment for depression, but experts say the evidence for this approach is not quite there yet.
Read this at Pharmaceutical Journal.
Share this:
Like this: